A. Hodge

Beta‐2‐microglobulin expression correlates with high‐grade prostate cancer and specific defects in androgen signaling

M. Gross, D. Agus, Anjali Jain, 2010, The Prostate.

Cancer-Associated Fibroblasts Derived from EGFR-TKI–Resistant Tumors Reverse EGFR Pathway Inhibition by EGFR-TKIs

D. Agus, Anjali Jain, Wenxuan Zhang, 2010, Molecular Cancer Research.

Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome

C. Skinner, C. Schwartz, G. Paré, 2017, Epigenetics & Chromatin.

Towards the genetic basis of cerebral venous thrombosis—the BEAST Consortium: a study protocol

M. Margaglione, J. Ferro, E. Grandone, 2016, BMJ Open.

HER kinase axis receptor dimer partner switching occurs in response to EGFR tyrosine kinase inhibition despite failure to block cellular proliferation.

D. Agus, Anjali Jain, C. Tindell, 2010, Cancer research.

Randomized controlled trial of docosahexaenoic acid supplementation in midwestern U.S. human milk donors.

M. Pennell, A. Morrow, L. Rogers, 2013, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

D. Agus, D. Bearss, Anjali Jain, 2009, Molecular Cancer Therapeutics.

Neonatal therapeutic hypothermia-associated hypomagnesemia during parenteral nutrition therapy.

J. Wispé, Amy A. Jones, C. Valentine, 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Genome‐Wide Association Study Identifies First Locus Associated with Susceptibility to Cerebral Venous Thrombosis

M. Margaglione, J. Ferro, S. Kittner, 2021, Annals of neurology.

Age of onset of cerebral venous thrombosis: the BEAST study

M. Margaglione, J. Ferro, E. Grandone, 2023, European stroke journal.